Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0U2QI
|
|||
| Former ID |
DIB006181
|
|||
| Drug Name |
METH-mab
|
|||
| Synonyms |
InterveXimab-METH; InterveXin-Meth; Methamphetamine antibody, InterveXion; Chimeric anti-methamphetamine monoclonal antibody (intravenous formulation, amphetamine dependence), University of Arkansas for Medical Sciences/InterveXion Therapeutics
Click to Show/Hide
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Methamphetamine dependence [ICD-11: 6C46.2; ICD-10: F15.2] | Phase 1 | [1] | |
| Company |
Intervexion therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800036212) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.